Community/Retail

Mental health interventions are a critical part of the global response to HIV, with multiple potential roles for psychiatrists and other mental health professionals.

It is possible that the pandemic had a positive impact on influenza vaccination rates.

Ivacaftor is now the first and only cystic fibrosis transmembrane conductance regulator modulator approved for this age group.

Clearer skin on the face and hands lasted 1 year into treatment.

In addition to streamlining and strengthening patient care, Dave said working in a medically integrated pharmacy can be incredibly rewarding for pharmacists.

More than half of patients with Alzheimer disease administered donanemab showed a significantly reduced cognitive and functional decline.

Dr. Christina Madison speaks with Walter Oronsaye PharmD, RPh, known as the Phit Pharmacist, about nutrition and social media as a pharmacist.

Study sheds light on the importance of the source of vaccine information and other factors that prevent lifesaving influenza or pneumococcal vaccination.

Misinformation on YouTube promotes women wiping front to back as a non-evidence-based hygiene practice to prevent urinary tract infection.

The advent of pharmacy-based community health workers has helped to expand and codify the pre-existing community-based efforts of pharmacy technicians to reach even outside of medication access.

Arexvy is the first respiratory syncytial virus (RSV) vaccine approved in the United States for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

A combination of cognitive behavioral therapy and medication had the most profound and stable result for patients suffering from insomnia.

Neutralizing monoclonal antibody therapies found to improve outcomes for unvaccinated and nonhospital patients at high risk of poor outcome for SARS-CoV-2.

Although these programs are not the entire solution to rising pharmacy costs, Marsh said they are an important part of solving the problem.

The COVID-19 pandemic revealed some of the major gaps in trust in the United States, but Johnson said pharmacists are key to improving it.

Recent editorial calls into question role, use of drug coverage for medications that often cost pennies to procure.

An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.

Naveen Mansukhani, BPharm, discussed skyrocketing prices for specialty drugs and what is driving those increases.

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.

Screening tools are becoming widely used to help clinicians address the needs of patients with diabetes to improve health outcomes.

The final approval was based on efficacy and safety data from the phase 3 REST-ON study.

Nearly 18-times more patients on trizepatide 15 mg achieved a body weight reduction of 15% or more compared to placebo.

Issues highlighted in May include mental illness as well as asthma and allergies.

Technicians, other support staff stepped up during the pandemic and took on new responsibilities, which should earn them permanent respect.

The flexible 1- and 2-month dosing intervals of risperidone could help address adherence challenges common with schizophrenia treatments.

Study shows intramuscular injection may improve treatment success by increasing the speed of drug absorption.

Analysis shows that the ratio of neutralizing antibody geometric mean titers in adolescents compared with young adults was 1.5 after vaccination with NVX-CoV2373.

Clinical interventions, follow-ups, medication reconciliation, patient education are key aspects of the programs.

The formulation in 960 mg and 720 mg prefilled syringes delivers sustained plasma concentrations comparable to those demonstrated in studies with Abilify Maintena.

Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.